BioMADE, a collaboration of public and private enterprise pursuing the manufacturing of "high-value" chemicals, materials, ...

LIfT BioSciences, (LIfT), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, announces progress in advancing the planned clinical trial for their Immunomodulatory Alpha ...

The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.

Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...

A $132 million manufacturing campus — where companies will transform crops into industrial chemicals otherwise made with petroleum and often sourced from overseas — is coming to Maple Grove. The ...